54
Views
11
CrossRef citations to date
0
Altmetric
Brief Report

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia – examination of practice in Germany

, , , , , , , , & show all
Pages 2751-2756 | Accepted 30 Jul 2008, Published online: 19 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

T. Steinmetz, M. Kindler, O. Lange, U. Vehling-Kaiser, A. Kuhn & E. Hellebrand. (2014) A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions. Current Medical Research and Opinion 30:9, pages 1813-1820.
Read now
J.G. Aerts, A. Swieboda-Sadlej, C. Karanikiotis, J.-L. Labourey, A. Galid, T. Wheeler, B. Pujol & S. Van Belle. (2012) Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study. Current Medical Research and Opinion 28:7, pages 1089-1099.
Read now
S. Van Belle, C. Karanikiotis, J.-L. Labourey, A. Galid, T. Wheeler & B. Pujol. (2011) Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy – data from the CHOICE study. Current Medical Research and Opinion 27:5, pages 987-994.
Read now

Articles from other publishers (8)

Dawn L. Hershman, Alfred I. Neugut, Jin Joo Shim, Sherry Glied, Wei-Yann Tsai & Jason D. Wright. (2014) Erythropoiesis-Stimulating Agent Use After Changes in Medicare Reimbursement Policies. Journal of Oncology Practice 10:4, pages 264-269.
Crossref
H. Tilman Steinmetz. (2014) Neben dem Hämoglobin ist das Eisen wichtig. Im Focus Onkologie 17:4, pages 39-43.
Crossref
Tilman Steinmetz, Kathrin Kuhr, Uwe Totzke, Martin Hellmich, Melanie Heinz, Michael Neise, Johann Mittermüller, Hans-Werner Tessen, Marcel Reiser, Kai Severin & Stephan Schmitz. (2013) Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients. Clinical Chemistry and Laboratory Medicine 51:9.
Crossref
Hartmut Link & Stephan Schmitz. (2013) Treatment of Cancer-Associated Anaemia: Results from a Two-Day Cross-Sectional Survey in Germany. Oncology Research and Treatment 36:5, pages 266-272.
Crossref
Kevin T. Stroupe, Elizabeth Tarlov, Todd A. Lee, Thomas W. Weichle, Qiuying L. Zhang, Laura C. Michaelis, Howard Ozer, Ramon Durazo‐Arvizu, Margaret M. Browning & Denise M. Hynes. (2012) Hemoglobin Levels Triggering Erythropoiesis‐Stimulating Agent Therapy in Patients with Cancer: the Shift After United States Food and Drug Administration Policy Changes. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:11, pages 988-997.
Crossref
H.Tilman Steinmetz. (2012) The role of intravenous iron in the treatment of anemia in cancer patients. Therapeutic Advances in Hematology 3:3, pages 177-191.
Crossref
Jason D. WrightAlfred I. NeugutElizabeth T. WildeDonna L. BuonoJennifer MalinWei Y. TsaiDawn L. Hershman. (2011) Physician Characteristics and Variability of Erythropoiesis-Stimulating Agent Use Among Medicare Patients With Cancer. Journal of Clinical Oncology 29:25, pages 3408-3418.
Crossref
T. STEINMETZ, U. TOTZKE, M. SCHWEIGERT, J. MITTERMÜLLER, S. NAWKA, H. TESCH, M. GROSCHEK, U. SÖLING, E. HELLEBRAND & A. TSAMALOUKAS. (2011) A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry. European Journal of Cancer Care 20:4, pages 493-502.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.